The most distinctive feature of coronary angioscopy is its ability to directly visualize the vessel. This allows direct observation of plaque natural history, including progression, rupture, and subsequent thrombus formation, in living patients. To date, coronary angioscopy has resulted in numerous discoveries, and we expect to find additional new phenomena using this technique. We introduced coronary angioscopy in 2002 and observed many surprising things. These included our observations of old saphenous vein grafts wherein dense, yellow plaques with numerous thrombi were observed in normal lesions. During the drug-eluting stent era, the healing process was observed to be absolutely different than after bare metal stent implantation. Following bare metal stent implantation, the stented site was covered with thick, white, smooth neointima; after implanting a first-generation drug-eluting stent, neointima formation was poor and the neointima was yellow, in some cases. This phenomenon, now called "neoatherosclerosis" was first observed using angioscopy. The cause of the yellow plaque formation was proven to be due to inflammation caused by the poor biocompatibility of the stent polymer. Developments in drug-eluting stent technology were clearly observed using angioscopy. Adequate healing after the implantation of second-generation drug-eluting stents was observed in stable coronary stenotic lesions; however, inadequate healing was observed in vulnerable lesions. Additional new technologies will be required to heal vulnerable lesions. In the near future, biodegradable vascular scaffolding will be available. Angioscopic observation of the healing process will be important to assess the safety of this new technology. Optical coherence tomography can also be used to observe and measure neointimal thickness after drug-eluting stent implantation. However, the layered thrombi attached to vessel walls cannot be assessed using this technology; angioscopy can clearly detect these thrombi. The hazy angiographic appearance of the lotus-root structures, sometimes seen using optical coherence tomography, were thought to be recanalized channels that formed after thrombosis. Angioscopy clearly showed these lotus-root observations to be due to fibrin nets. The characteristics of plaques, after stent implantation involving tissue protrusion, were also unclear; however, angioscopy identified the exact tissue characteristics and allowed the suggestion of further therapies. Recently, the angioscopic observation of the aorta has been a focus. Various thrombi and plaques may be observed on the surface of the aorta. Understanding these structures may elucidate the mechanism of acute aortic syndrome. Angioscopy is the only tool that allows the direct observation of the intravascular world and has a high potential for allowing new discoveries in living people.
Introduction
What makes the use of angioscopy so attractive? The most distinctive feature of coronary angioscopy is its ability to directly visualize the coronary artery; seeing is believing. Many coronary artery happenings are only able to be observed using angioscopy. Angioscopy is the only tool that allows the direct observation of plaque natural history, including its progression, sometimes its regression, and finally its rupture and the subsequent thrombus formation, in living patients. To date, coronary angioscopy has allowed many new discoveries and we expect to discover additional new phenomena using this technique. Our institute introduced coronary angioscopy in 2002, and its use has allowed us to observe many surprising things. In this review, we describe angioscopic findings that cannot be detected using other modalities.
Old Saphenous Vein Grafts
Saphenous veins are an important source of coronary arteries for aorta bypass grafting. After grafting, arterialization of a saphenous vein graft (SVG) is thought to accelerate atherosclerosis. Indeed, the 10-year patency rate for SVGs is less than 60%. 1) To understand the precise mechanism of SVG degeneration, angioscopic observations were performed using old SVGs.
Surprisingly, dense yellow plaques and various thrombi were angiographically observed throughout normal lesions ( Fig. 1 ).
2)
This phenomenon was also detected using optical coherence tomography (OCT). 3, 4) In an attempt to understand this phenomenon, we analyzed the factors affecting SVG degeneration.
Thrombi and plaques were semiquantitatively assessed and compared with coronary risk factors and laboratory data. Positive relationships were found with the number of risk factors that patients had, as well as with their glycosylated hemoglobin (HbA1c) values. 5) 
Stent Observations

Bare metal stents
Angioscopy has played an important role in understanding plaque healing after stent implantation. Since the bare metal stent (BMS) era, our institute has studied the post-stenting healing process. Chronic follow-up angioscopy, after PCIs involving the implantation of BMSs, revealed that thick, white, smooth neointima, without thrombi, fully covered the stent struts; the struts were not visible even after an acute coronary syndrome (ACS) event involving complex yellow plaque and thrombi in the culprit lesion. Therefore, this phenomenon was understood to yield plaque sealing and stabilization. 7) As mentioned previously, BMS segments avoid the development of in-stent restenosis (ISR) were considered to demonstrate favorable healing within a couple of years. According to long-term angioscopic follow-up examinations, the neointima became thinner and increasingly transparent within 3 years after BMS implantation. 8) Angiographic observations sometimes indicated that the minimum luminal diameter, at the BMS implantation site, also became slightly dilated compared with the 6-month follow-up examination. This phenomenon was thought to be identical to the angioscopic observation of thin neointima formation.
First generation drug-eluting stents (1st-G DES)
In the DES era, angioscopic studies have been more important for helping to understand the post-DES implantation healing process. To overcome ISR, DESs were developed, including sirolimus-eluting stents (SESs) and paclitaxel-eluting stents (PESs). Since their introduction, these two DES types have been termined by 4 grading system, Grade 0 was defined as stent struts that were fully visible, similar to immediately after implantation. Grade 1 was defined as stent struts that bulged into the lumen and although covered, were still transparently visible.
Grade 2 was defined as stent struts that were visible, but not clearly seen. Grade 3 was defined as stent struts that were not visible by angioscopy. This grading system has been used in numerous angioscopic investigations. Many reports have described the poor and delayed neointima formation after 1st-G DES implantation. 10, 11) Poor neointimal coverage, after 1st-G DES implantation, is thought to be one of the mechanisms contributing to LST and VLST. This phenomenon was observed to continue for up to 2 years. 12) So, a consideration of the need for continued dual anti-platelet therapy seems to be important. Another mechanism resulting in LST and VLST was neoatherosclerosis. This plaque healing concept was first reported following angioscopic observations. After the introduction of the 1st-G DESs, the DES effects on plaque stabilization were expected to be similar to those associated with BMSs; however, plaque healing following implantation of 1st-G DESs was completely different. In 2006,
we reported the formation of yellow neointima 3 months after SES implantation. 13) In that study, we clearly demonstrated that the frequency of yellow plaque increased 3 months after stenting ( The narrowing site is opened using a sirolimus-eluting stent. The small letters in the left panel correspond with the angioscopy images (right panels), immediately after PCI (a-c). The stent struts are clearly seen, with sharp light reflection. Red thrombi are evident under the stent strut (a) and the plaque is white. (C) Ninety-seven days after stent implantation, in-stent restenosis is not evident at the stented site. The small letters in the left panel correspond with the angioscopy images. Using angioscopy, the stent struts are visible, without light reflection (black arrow in panels b' , c' ). The plaque color has changed from white to yellow (* in a' , b' ) and white thrombus covering the stent strut (white arrow in c' ) is evident. a and a' : proximal lesion of the stent; b and b' : mid-portion of the stent; c and c' : distal lesion of the stent 13) tually ruptured, resulting in ACS, which is another mechanism of VLST development. Figure 3 demonstrates visible at the PSS site. In this case, the cause of the PSS was thought to be SES-induced inflammation. As described above, angioscopy played an important role in understanding plaque healing after 1st-G DES implantation. Figure 4 shows the mechanism of ISR and VLST development, based on our observations of angioscopy.
Second-generation (2nd-G) DESs
Considering the disadvantages of the 1st-G DESs, drug pharmacokinetics and drug-carrying polymers were improved for the next generation of DESs. In the fast-release zotarolimus-eluting stent (E-ZES), at least 90% of the drug releases within 2 weeks of stent implantation. Thus, drug release from E-ZESs occurs earlier than for 1st-G DESs. Therefore, the post-E-ZES implantation healing response occurs earlier than after 1st-G DES implantation, and mimics that of BMSs. Following E-ZES implantation, a thicker neointima covers the stent struts than that associated with 1st-G DESs.
17) E-ZESs may also provide sufficient plaque sealing, similar to that associated with BMSs. The approaches used with everolimus-eluting stents (EESs) and slow 
Third-generation (3rd-G) DESs
Further development of the polymer technology resulted in the 3rd-G DESs that have an abluminal, bioabsorbable polymer that contains drug; the stent eventually becomes a BMS as the polymer is bioabsorbed. The drug is released within about 3 months and the polymer is fully absorbed 4-6 months after stenting.
These devices seem to have better vascular healing and prevent early neointima formation. We are currently investigating the vascular response after 3rd-G DES implantation and comparing that with the responses following 2nd-G DES implantation. Our impression is that the neointima thickness, following 3rd-G DES implantation, is thicker than that which forms after 2nd-G DES implantation. However, the grade of yellow neointima is less than that associated with 2nd-G DESs. The answer to the question of which generation of DES is better remains unknown, currently.
In the near future, biodegradable vascular scaffolding will be available. Angioscopic observation of the healing process associated with these types of devices will be important to fully assess the safety of this new technology.
ISR after DES implantation
Since the introduction of DESs, the problem of ISR was thought to be almost completely solved; however, ISR is rarely experienced after DES implantation. The mechanism of early stage ISR, after BMS implantation, was thought to consist mostly of smooth muscle proliferation; white plaque is angioscopically visible at the ISR lesion. However, various mechanisms exist for the development of ISR, after DES implantation.
One of these mechanisms is neoatherosclerosis. We experienced that ISR lesion was treated using a BMS, with the expectation that the BMS would result in the sealing of the atheroma. In this case, the attempt was successful. Thick, white neointima covered the ISR lesion, without restenosis being observed at the follow-up examination. 20) This case suggests that angioscopic observation directly impacts the choice of an effective therapy.
OCT and Angioscopy
Recent intravascular imaging procedures have frequently involved the use of OCT. Neointimal healing, after DES implantation, can be quantitatively assessed using OCT, and many investigators have reported 21, 22) and believed their OCT findings. Indeed, OCT can detect thin neointima-covered stent struts early after DES implantation; the thickness of the neointimal coverage can also be measured. However, the coverage of stent struts by layers of thrombi cannot be assessed using OCT, whereas angioscopy can clearly detect these thrombi. Figure 6 shows covered struts, 3 weeks after EES implantation. The struts were covered by a low-signal material, based on OCT determinations; therefore, we thought that the stent strut coverage was adequate after 3 weeks. We then performed angioscopy to observe the early-stage neointima. Unbelievably, the stent struts were covered by thin, red thrombi. This observation indicated that qualitative analyses using angioscopy, after stent implantation, are superior to those using other modalities.
Lotus-root Appearance Imaging by OCT
The angiographic appearance of haziness sometimes manifests as a lotus-root appearance when using and OCT. The mechanism responsible for this manifestation remains unclear, but it is thought to represent channel recanalization, after thrombosis.
Angioscopy clearly shows that the cause of this lotus-root appearance is the presence of a fibrin net. Figure 7 shows angiographic haziness with moderate stenosis at the left anterior descending artery. To assess the lumen profile and plaque characteristics, we attempted an OCT evaluation that revealed a lotus-root appearance. To clarify this observation, we performed angioscopy, which clearly showed a fibrin net formation at the site. This fibrin net was thought to be a recanalized thrombus. 23) Based on this observation, a scoring balloon was used to cut the fibrin net before stenting.
Tissue Protrusion Immediately after Stent Implantation
We sometimes experience tissue protrusions after stent implan- 
Conclusion
Since the introduction of angioscopy, we have observed many surprising things in living people; this from a tool used to observe blood flow in a living condition. Seeing is believing. We will continue to use this sophisticated modality to find the wonders of the intravascular world.
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